Our Department of Biostatistics is recognized as a worldwide leader in research and practice. Members of our faculty are interested both in the development of statistical methodology and application of statistics in applied research.
Coronavirus Affects Everyone: The Department of Biostatistics Responds
While the world was learning a hard lesson this past year about the speed with which a pandemic can spread, it also was seeing how rapidly effective testing, treatments and protocols can be developed when the biomedical research community comes together in search of solutions. Gillings Biostatistics faculty members have played key roles in those critical advances in many areas - from designing master protocols, to investigating treatments, to conducting statistical research on optimal end points for clinical trials, to modeling the spread of the disease itself. And others are actively working with interdisciplinary teams to help society prepare for the next pandemic – because what we can say with certainty is that there will be one. The world of biomedicine is clearly moving quickly, and Gillings biostatistics thought leaders are engaged and contributing, every step of the way.
Research Strengths
- Development of new statistical methods to address pressing issues in medicine and public health sciences
- Design of innovative clinical trials that allow faster evaluation of new therapeutic agents
- Collaborative work focused upon important public health concerns, including infectious diseases, cancer, cardiovascular disease and obesity
- Utilization of strong quantitative skills to improve the health of human beings around the globe
Message from the Chair
